Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

News Corporation Discloses ASX Share Repurchase Filings

News Corporation filed a Form 8-K on August 10, 2026, reporting the attachment of share repurchase transaction disclosures provided to the Australian Securities Exchange on dates noted in the accompanying exhibits.

Anjali Anand | 10 August 2026

Sionna Therapeutics Releases Topline Data for SION-719 and SION-451

Sionna Therapeutics, Inc. filed a Form 8-K on August 10, 2026, announcing topline data from its PreciSION CF Phase 2a proof-of-concept trial of SION-719 and its Phase 1 trial of SION-451-based proprietary dual combinations, along with a corporate update on next steps.

Shwetambri Chauhan | 10 August 2026

Tenax Therapeutics Reports Phase 3 LEVEL Trial Topline Results

Tenax Therapeutics, Inc. filed a current report on Form 8-K on August 10, 2026, announcing topline results from its Phase 3 LEVEL clinical trial of TNX-103 in patients with PH-HFpEF, along with a conference call and live webcast held the same day.

Manish Choudhary | 10 August 2026

Surgery Partners Reports Q2 and First-Half 2026 Results

Surgery Partners, Inc. filed a current report on August 10, 2026, announcing financial results for the three and six months ended June 30, 2026, along with a scheduled investor conference call for the same date.

Vinay Lochav | 10 August 2026

Liberty Media Proposes $600 Million Convertible Notes Offering

Liberty Media Corporation filed an 8-K with the U.S. Securities and Exchange Commission on August 10, 2026, disclosing a proposed offering of $600 million aggregate principal amount of convertible senior notes due 2032.

Aditi Sarkar | 10 August 2026

SunocoCorp LLC Announces Two Investor Conference Appearances

SunocoCorp LLC filed a current report on August 10, 2026, disclosing plans for senior management to participate in investor meetings at two energy industry conferences in August and September 2026.

Vinay Lochav | 10 August 2026

GCM Grosvenor Reports Q2 and H1 2026 Financial Results

GCM Grosvenor Inc. filed a current report on August 10, 2026, disclosing financial results for the three and six months ended June 30, 2026, with a press release and earnings presentation furnished as exhibits.

Vinay Lochav | 10 August 2026

AbCellera Reports Phase 2 Top-Line Results for ABCL635

AbCellera Biologics Inc. filed a current report on August 10, 2026, announcing positive top-line results from the Phase 2 portion of its Phase 1/2 clinical trial evaluating ABCL635, an investigational neurokinin 3 receptor antagonist antibody.

Vinay Lochav | 10 August 2026

MarineMax Agrees to $53.00-Per-Share Cash Merger

MarineMax, Inc. filed a current report on August 10, 2026, disclosing that on August 9, 2026, it entered into an Agreement and Plan of Merger with SHM Holdco, LLC and Intrepid Holdco, Inc., affiliates of Safe Harbor Marinas, LLC, a portfolio company of Blackstone …

Aakashdeep | 10 August 2026

Replimune Group Prices Public Offering of Common Stock

Replimune Group, Inc. filed a current report on August 10, 2026, disclosing that on August 9, 2026, the company entered into an underwriting agreement for a public offering of common stock and pre-funded warrants, with estimated net proceeds of approximately $140.5 million.

Aditi Sarkar | 10 August 2026
Support

Hi! How can we help you today?

Loading…